IVERMECTIN vs JUXTAPID: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IVERMECTIN vs JUXTAPID: Safety Overview
| Metric | IVERMECTIN | JUXTAPID |
|---|---|---|
| Total FAERS Reports | 3,018 | 179 |
| Deaths Reported | 221 | 2 |
| Death Rate | 7.3% | 1.1% |
| Hospitalizations | 600 | 13 |
| Average Patient Age | 53.3 yrs | 58.0 yrs |
| % Female Patients | 59.7% | N/A |
| FDA Approval Date | Apr 13, 2020 | N/A |
| Manufacturer | Asclemed USA, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | N/A |